
James William Rogers
Examiner (ID: 18141, Phone: (571)272-7838 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1196 |
| Issued Applications | 505 |
| Pending Applications | 144 |
| Abandoned Applications | 587 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18497316
[patent_doc_number] => 20230219933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => STERICALLY SHIELDED HEPTAMETHINE CYANINE DYES
[patent_app_type] => utility
[patent_app_number] => 17/996420
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996420
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996420 | Sterically shielded heptamethine cyanine dyes | Feb 21, 2021 | Issued |
Array
(
[id] => 18012065
[patent_doc_number] => 11504339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Compositions comprising urolithin a and uses thereof in treating kidney injury
[patent_app_type] => utility
[patent_app_number] => 17/160836
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16022
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17160836
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/160836 | Compositions comprising urolithin a and uses thereof in treating kidney injury | Jan 27, 2021 | Issued |
Array
(
[id] => 17759970
[patent_doc_number] => 20220233582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => Silicone Face Mask For Skin Treatment
[patent_app_type] => utility
[patent_app_number] => 17/156619
[patent_app_country] => US
[patent_app_date] => 2021-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17156619
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/156619 | Silicone Face Mask For Skin Treatment | Jan 23, 2021 | Abandoned |
Array
(
[id] => 18279130
[patent_doc_number] => 20230094602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => NOVEL GADOLINIUM-BASED COMPOUND, PREPARATION METHOD THEREFOR, AND MRI CONTRAST AGENT CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 17/794807
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794807
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794807 | Gadolinium-based compound, preparation method therefor, and MRI contrast agent containing same | Jan 21, 2021 | Issued |
Array
(
[id] => 18319699
[patent_doc_number] => 20230117827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => COMPOSITION COMPRISING A FLUOROPHORE LABELLED UPAR-TARGETING PEPTIDE CONJUGATE
[patent_app_type] => utility
[patent_app_number] => 17/792336
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792336 | COMPOSITION COMPRISING A FLUOROPHORE LABELLED UPAR-TARGETING PEPTIDE CONJUGATE | Jan 14, 2021 | Pending |
Array
(
[id] => 17005499
[patent_doc_number] => 20210236660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => IMAGEABLE POLYMERS
[patent_app_type] => utility
[patent_app_number] => 17/150310
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150310
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150310 | IMAGEABLE POLYMERS | Jan 14, 2021 | Pending |
Array
(
[id] => 17702604
[patent_doc_number] => 20220202610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => CONTACT LENS WITH SUSTAINED RELEASE PROPERTY
[patent_app_type] => utility
[patent_app_number] => 17/139360
[patent_app_country] => US
[patent_app_date] => 2020-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17139360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/139360 | CONTACT LENS WITH SUSTAINED RELEASE PROPERTY | Dec 30, 2020 | Abandoned |
Array
(
[id] => 16778190
[patent_doc_number] => 20210115268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => FUNCTIONALIZED QUATERNARY AMMONIUM HALIDES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/137564
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137564
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/137564 | FUNCTIONALIZED QUATERNARY AMMONIUM HALIDES AND USE THEREOF | Dec 29, 2020 | Abandoned |
Array
(
[id] => 18280235
[patent_doc_number] => 20230095707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => MULTIMODAL FLUORINE-CY3/5/7-DOTA-HAPTEN COMPOSITIONS, DIAGNOSTICS, FLUORESCENCE GUIDED SURGERY AND RADIOIMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/790079
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790079
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790079 | Multimodal fluorine-CY3/5/7-DOTA-hapten compositions, diagnostics, fluorescence guided surgery and radioimmunotherapy | Dec 29, 2020 | Issued |
Array
(
[id] => 16762354
[patent_doc_number] => 20210107935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => NOVEL, HEAVY VITAMIN B12 DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/128511
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17128511
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/128511 | Heavy vitamin B12 derivatives | Dec 20, 2020 | Issued |
Array
(
[id] => 18282966
[patent_doc_number] => 20230098438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/790698
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790698
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790698 | OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING | Dec 20, 2020 | Pending |
Array
(
[id] => 18159274
[patent_doc_number] => 20230025866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/787545
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787545 | NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES | Dec 17, 2020 | Pending |
Array
(
[id] => 16719995
[patent_doc_number] => 20210087142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS
[patent_app_type] => utility
[patent_app_number] => 17/116501
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116501
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116501 | Formulation for soft anticholinergic analogs | Dec 8, 2020 | Issued |
Array
(
[id] => 16717751
[patent_doc_number] => 20210084898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => METHOD OF USING HYDROPHILIZED BACTERICIDAL POLYMERS
[patent_app_type] => utility
[patent_app_number] => 17/115709
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17115709
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/115709 | Method of using hydrophilized bactericidal polymers | Dec 7, 2020 | Issued |
Array
(
[id] => 18280579
[patent_doc_number] => 20230096051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => CGRP ANTIGONISTS USEFUL AS TRACER COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 17/784215
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784215 | CGRP ANTIGONISTS USEFUL AS TRACER COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY | Dec 3, 2020 | Abandoned |
Array
(
[id] => 16883845
[patent_doc_number] => 20210170040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/112541
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112541
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112541 | DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY | Dec 3, 2020 | Abandoned |
Array
(
[id] => 16760958
[patent_doc_number] => 20210106539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => DELIVERY OF DRUG NANOPARTICLES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/112674
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112674 | Delivery of drug nanoparticles and methods of use thereof | Dec 3, 2020 | Issued |
Array
(
[id] => 18485020
[patent_doc_number] => 20230212340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY
[patent_app_type] => utility
[patent_app_number] => 17/781731
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781731 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | Dec 3, 2020 | Pending |
Array
(
[id] => 18273739
[patent_doc_number] => 11612660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Dendrimer compositions and methods for drug delivery to the eye
[patent_app_type] => utility
[patent_app_number] => 17/112255
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 20
[patent_no_of_words] => 20646
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112255 | Dendrimer compositions and methods for drug delivery to the eye | Dec 3, 2020 | Issued |
Array
(
[id] => 16718678
[patent_doc_number] => 20210085825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => CROSSLINKABLE POLYMER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/111878
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17111878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/111878 | Crosslinkable polymer compositions | Dec 3, 2020 | Issued |